| Coordinate regulation of mutant NPC1 degradation by selective ER autophagy and MARCH6-dependent ERAD ML Schultz, KL Krus, S Kaushik, D Dang, R Chopra, L Qi, VG Shakkottai, ... Nature communications 9 (1), 3671, 2018 | 113 | 2018 |
| Phenotypic outcomes in Mouse and Human Foxc1 dependent Dandy-Walker cerebellar malformation suggest shared mechanisms P Haldipur, D Dang, KA Aldinger, OK Janson, F Guimiot, H Adle-Biasette, ... Elife 6, e20898, 2017 | 34 | 2017 |
| Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas P Panwalkar, B Tamrazi, D Dang, C Chung, S Sweha, SK Natarajan, ... Science translational medicine 13 (614), eabc0497, 2021 | 31 | 2021 |
| Evidence of disrupted rhombic lip development in the pathogenesis of Dandy–Walker malformation P Haldipur, S Bernardo, KA Aldinger, T Sivakumar, J Millman, ... Acta neuropathologica 142, 761-776, 2021 | 25 | 2021 |
| SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors P Panwalkar, D Pratt, C Chung, D Dang, P Le, D Martinez, JM Bayliss, ... Neuro-oncology 22 (6), 785-796, 2020 | 23 | 2020 |
| Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations HJ Roberts, S Ji, A Picca, M Sanson, M Garcia, M Snuderl, U Schüller, ... Acta Neuropathologica 146 (6), 849-852, 2023 | 13 | 2023 |
| β-catenin–driven differentiation is a tissue-specific epigenetic vulnerability in adrenal cancer DR Mohan, KS Borges, I Finco, CR LaPensee, J Rege, AL Solon, ... Cancer research 83 (13), 2123-2141, 2023 | 6 | 2023 |
| A road map for the treatment of pediatric diffuse midline glioma C Koschmann, WN Al-Holou, MM Alonso, J Anastas, P Bandopadhayay, ... Cancer cell 42 (1), 1-5, 2024 | 5 | 2024 |
| β-catenin programs a tissue-specific epigenetic vulnerability in aggressive adrenocortical carcinoma DR Mohan, KS Borges, I Finco, CR LaPensee, J Rege, AL Solon, ... bioRxiv, 2022.07. 02.497654, 2022 | 1 | 2022 |
| MDB-78. ISOCITRATE DEHYDROGENASE 1 INHIBITION PRIMES GROUP-3 MEDULLOBLASTOMAS FOR CUPROPTOSIS D Dang, J McKolay, K Smith, P Panwalkar, S Sweha, SK Natarajan, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| Beyond the Warburg Effect: A Study of Metabolic Alterations in Malignancies of the Posterior Fossa D Dang | | 2024 |
| ZFTA-RELA fusion aberrantly drives glutamine metabolism in lethal pediatric ependymomas SK Natarajan, J Haggerty-Skeans, J Lum, P Narayanan, S Sweha, S Sunil, ... Cancer Research 83 (7_Supplement), 6047-6047, 2023 | | 2023 |
| Epigenetic dedifferentiation as a therapeutic strategy in adrenal cancer DR Mohan, KS Borges, I Finco, CR LaPensee, J Rege, DW Little, T Else, ... Cancer Research 83 (7_Supplement), 1501-1501, 2023 | | 2023 |
| Investigating metabolic dependencies of group 3 medulloblastoma D Dang, KS Smith, P Panwalkar, J McKolay, O Animasahun, A Achreja, ... Cancer Research 83 (7_Supplement), 6041-6041, 2023 | | 2023 |
| GENE-50. SWI/SNF COMPLEX HETEROGENEITY RELATES WITH POLYPHENOTYPIC DIFFERENTIATION, PROGNOSIS AND IMMUNE RESPONSE IN RHABDOID TUMORS S Venneti, P Panwalkar, D Pratt, C Chung, D Dang, P Lee, D Martinez, ... Neuro-Oncology 21 (Supplement_6), vi108-vi108, 2019 | | 2019 |
| ATRT-10. HETEROGENEITY OF BAF AND PBAF SWI/SNF COMPLEX SUBUNITS IN MALIGNANT RHABDOID TUMORS RELATES WITH POLYPHENOTYPIC DIFFERENTIATION AND THE IMMUNE MICROENVIRONMENT A TERATOID, I APOPOTOSIS Neuro-oncology, 2019 | | 2019 |
